Blood Amyloid-beta Oligomerization as a Biomarker of Alzheimer's Disease: A Blinded Validation Study. Youn YC, Lee BS, Kim GJ, Ryu JS, et al. J Alzheimers Dis 2020 Apr 9. pii: JAD200061. doi: 10.3233/JAD-200061.

Read + Share

Amedeo Smart

Independent Medical Education

Youn YC, Lee BS, Kim GJ, Ryu JS, et al. Blood Amyloid-beta Oligomerization as a Biomarker of Alzheimer's Disease: A Blinded Validation Study. J Alzheimers Dis 2020 Apr 9. pii: JAD200061. doi: 10.3233/JAD-200061.
PMID: 32310175